Details for Patent: 10,028,858

Which drugs does patent 10,028,858 protect, and when does it expire?

Patent 10,028,858 protects LILETTA and is included in one NDA.

This patent has twenty-four patent family members in nineteen countries.

Summary for Patent: 10,028,858

Title:	Intrauterine systems, IUD insertion devices, and related methods and kits therefor
Abstract:	Intrauterine systems and components thereof. The systems include an intrauterine device (IUD), an insertion device or applicator for inserting the IUD into the cervix of a female patient. The insertion device includes an elongated sheath; an elongated inner member positioned within a lumen of the elongated sheath; a handle with one or more elongated guides; and a moveable sheath slider. Additionally, methods related to the insertion procedure, and methods of manufacture for the insertion device.
Inventor(s):	Deckman; Rob (San Bruno, CA), Repp; Richard E. (San Jose, CA), Guyer; Curt (Dublin, CA), Westendorf; Justin (Santa Clara, CA), Parmer; Timothy (Brooklyn Park, MN)
Assignee:	Medicines360 (San Francisco, CA)
Application Number:	13/539,843
Patent Claim Types: see list of patent claims	Use; Device;

Drugs Protected by US Patent 10,028,858

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Medicines360	LILETTA	levonorgestrel	INTRAUTERINE DEVICE;INTRAUTERINE	206229-001	Feb 26, 2015		RX	Yes	Yes			Y			A METHOD FOR PREVENTION OF PREGNANCY

International Family Members for US Patent 10,028,858

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2012282832
Australia	2015221468
Brazil	112014000440
Brazil	122015016218